BioFactors

Preface
pp. 181-182(2)
Author: Salganicoff L.

International Conference Challenges in the Study of Encephalomyopathies of Mitochondrial Origin
pp. 183-185(3)

Mitochondrial biology, degenerative diseases and aging
pp. 187-190(4)
Authors: Wallace D.C.; Brown M.D.; Melov S.; Graham B.; Lott M.

Mitochondrial diseases: genetics
pp. 191-195(5)
Authors: Schon E.A.; Grossman M.H.

Transfer of nuclear proteins to mitochondria – a role in mitochondrial disease
pp. 197-199(3)
Author: Fenton W.A.

Fatty acid metabolism in mitochondria: Defects and genetics
pp. 201-202(2)
Author: Coates P.M.

Nuclear-mitochondrial intergenomic communication
pp. 203-205(3)
Author: Clayton D.A.

Mitochondrial free radical damage and DNA repair
pp. 207-208(2)
Authors: Richter C.; Suter M.; Walter P.B.

Problems in the diagnosis of mitochondrial cytopathies: Introduction
pp. 209-212(4)
Authors: Salganicoff L.; Selak M.

Biochemical methods for diagnosis of mitochondrial cytopathies: Introduction and perspectives
pp. 213-215(3)
Author: Ernster L.

Use of isolated mitochondria as a tool for biochemical characterization of neuromuscular disorders
pp. 217-219(3)
Author: Lee C.P.

Use of saponin-permeabilized muscle fibers for the diagnosis of mitochondrial diseases
pp. 221-223(3)
Authors: Kuznetsov A.V.; Wiedemann F.R.; Winkler K.; Kunz W.S.

Disturbances in mitochondrial transport systems leading to encephalomyopathies
pp. 225-227(3)
Authors: Trijbels F.; Huizing M.; Ruitenbeek W.; Sengers R.; Smeitink J.; DePinto V.; Wendel U.

Diagnosis of mitochondrial energy metabolism defects in tissue culture. Induction of MnSOD and bcl-2 in mitochondria from patients with complex I (NADH-CoQ reductase) deficiency
pp. 229-230(2)
Authors: Robinson B.H.; Luo X.P.; Pitkänen S.; Bratinova S.; Bourgeois J.; Lehotay D.C.; Raha S.

Ultrastructural alterations in encephalomyopathies of mitochondrial origin
pp. 231-236(6)
Authors: Bonilla E.; Tanji K.

Noninvasive approaches to mitochondrial myopathies: Optical spectroscopy and imaging
pp. 237-238(2)
Authors: Chance B.; Park J.; Bank W.; Nioka S.; Lech G.; Hong L.

Near-infrared spectrophotometry: Introduction
pp. 239-242(4)
Author: Salganicoff L.

Near-infrared spectroscopy in the diagnosis of mitochondrial disorders
pp. 243-245(3)
Authors: Bank W.; Park J.; Lech G.; Chance B.

Introduction to magnetic resonance spectroscopy (MRS) and positron emission tomography (PET) for the investigation of mitochondrial myopathies
pp. 247-249(3)
Author: Radda G.K.

The study of mitochondrial diseases using magnetic resonance spectroscopy
pp. 251-252(2)
Author: Radda G.K.

Correlative magnetic resonance and near-infrared technologies for the evaluation of mitochondrial disease
pp. 253-254(2)
Authors: Park J.; Bank W.; Lech G.; Long H.; Olsen N.; Chance B.

Positron emission tomography in mitochondrial diseases
pp. 255-257(3)
Author: Chugani H.T.

Diet change in the management of metabolic encephalomyopathies
pp. 259-262(4)
Authors: Haas R.H.; Barshop B.A.

Redox regulation of cell functions by \alpha -lipoate: biochemical and molecular aspects
pp. 263-267(5)
Authors: Roy S.; Packer L.

Leigh syndrome: Historical perspective and clinical variations
pp. 269-271(3)
Author: De Vivo D.C.

Biochemical defects and genetic abnormalities in cytochrome c oxidase of patients with Leigh syndrome
pp. 273-276(4)
Authors: Kadenbach B.; Possekel S.; Hüttemann M.; Arnold S.

Mitochondrial diseases: Clinical considerations
pp. 277-285(9)
Author: DiMauro S.